Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
37.70
-0.05 (-0.13%)
Sep 9, 2025, 10:25 AM - Market open
Collegium Pharmaceutical Employees
Collegium Pharmaceutical had 357 employees as of December 31, 2024. The number of employees increased by 160 or 81.22% compared to the previous year.
Employees
357
Change (1Y)
160
Growth (1Y)
81.22%
Revenue / Employee
$1,980,412
Profits / Employee
$101,599
Market Cap
1.19B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 357 | 160 | 81.22% |
| Dec 31, 2023 | 197 | -10 | -4.83% |
| Dec 31, 2022 | 207 | 55 | 36.18% |
| Dec 31, 2021 | 152 | -82 | -35.04% |
| Dec 31, 2020 | 234 | -21 | -8.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COLL News
- 17 hours ago - Collegium Pharmaceutical, Inc. (COLL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 12 days ago - Collegium to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 15 days ago - Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting - GlobeNewsWire
- 4 weeks ago - Collegium Pharmaceutical, Inc. (COLL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook - GlobeNewsWire
- 6 weeks ago - Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 2 months ago - Collegium Announces $150 Million Share Repurchase Program - GlobeNewsWire
- 2 months ago - Collegium Pharmaceutical: Stock Deserves A "Buy" Call On Undervaluation Of ADHD Drug - Seeking Alpha